Canopy Growth Announces Offtake Agreement With Pharmhouse

Media: Rob Small, Senior Manager, Public Relations – Communications,; Investor Relations: ir@canopyrivers.comCopyright CNW Group 2020 Canopy Rivers is a unique investment and operating platform structured to continue investments in the global cannabis sector. Canopy Rivers is working with Canopy Growth (TSX:WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operational support. Canopy Rivers has developed an investment ecosystem of complementary cannabis companies that represent different segments of the value chain in the emerging cannabis sector. As the portfolio evolves, voters will have the opportunity to work and work together with Canopy Growth, which Canopy Rivers believes will maximize shareholder value and foster an environment of innovation, synergy and value creation for the entire ecosystem. The company is proud to educate physicians, undertake robust clinical research and promote public understanding of cannabis, and through its wholly owned subsidiary Canopy Health Innovations (“Health Health”), it has spent millions of dollars on commercial research and IP development. Canopy Growth is working with the Beckley Foundation and has launched Beckley Canopy Therapeutics to study and develop clinically validated drugs for cannabis, with a strong focus on intellectual property protection. Canopy Growth has acquired assets from the leading hemp research company ebbu, Inc. (“ebbu”). Intellectual property (“IP”) and the ebbu team`s research and development advances apply directly to Canopy Growth`s hemp and THC-rich cannabis breeding program and its cannabis use capabilities.

Through Canopy Rivers Corporation, a wholly-owned subsidiary, it provides resources and investments to new entrants and creates a portfolio of stable investments in this sector. About Canopy Rivers Canopy Rivers is a venture capital firm specializing in cannabis, with a portfolio of 18 companies in different segments of the cannabis value chain. We believe that bringing people, money and ideas together increases the potential of the entire cannabis industry. Using our industry visions, internal know-how and investment thesis, we want to expose shareholders to specialized and disruptive cannabis companies.